Department of the Army, DoD.
Announcement is made of the availability for licensing of the invention set forth in U.S. Patent Application Serial No. 11/132,199, entitled “Construction of Live Attenuated Shigella Vaccine Strains that Express CFA/I Antigens (CFAB and CFAE) and the B Subunit of Heat-Labile Enterotoxin (LTB) From Enterotoxigenic E. Coli,” filed May 19, 2005. The United States Government, as represented by the Secretary of the Army, has rights to this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research and Technology Applications (ORTA), (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
The invention relates to materials and methodologies for preparing multivalent vaccines, recombinant DNA expression Start Printed Page 39668products and more particularly to vector constructs which effectively express the cfaB, cfaE and LTB proteins in Shigella spp. without affecting the ability of the Shigella strain to invade cells of the colonic epithelium following oral administration to humans.Start Signature
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-16891 Filed 7-9-10; 8:45 am]
BILLING CODE 3710-08-P